End-of-day quote
Korea S.E.
06:00:00 2024-07-04 pm EDT
|
5-day change
|
1st Jan Change
|
2,625
KRW
|
-0.76%
|
|
-2.23%
|
-21.41%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
38,397
|
37,608
|
57,189
|
52,490
|
39,814
|
43,104
|
Enterprise Value (EV)
1 |
38,530
|
36,672
|
52,187
|
47,838
|
40,122
|
37,214
|
P/E ratio
|
10.4
x
|
9.3
x
|
26.1
x
|
22.3
x
|
18.6
x
|
14
x
|
Yield
|
2.65%
|
2.52%
|
1.64%
|
-
|
-
|
2.1%
|
Capitalization / Revenue
|
1.07
x
|
0.92
x
|
1.31
x
|
1.35
x
|
0.86
x
|
0.84
x
|
EV / Revenue
|
1.07
x
|
0.89
x
|
1.19
x
|
1.23
x
|
0.87
x
|
0.72
x
|
EV / EBITDA
|
8.74
x
|
7.64
x
|
14.5
x
|
30.6
x
|
16.7
x
|
15.7
x
|
EV / FCF
|
47.8
x
|
39
x
|
11.3
x
|
-147
x
|
-9.4
x
|
5.7
x
|
FCF Yield
|
2.09%
|
2.56%
|
8.84%
|
-0.68%
|
-10.6%
|
17.6%
|
Price to Book
|
1.13
x
|
1.08
x
|
1.61
x
|
1.45
x
|
1.08
x
|
1.08
x
|
Nbr of stocks (in thousands)
|
14,544
|
13,528
|
13,425
|
13,425
|
12,906
|
12,906
|
Reference price
2 |
2,640
|
2,780
|
4,260
|
3,910
|
3,085
|
3,340
|
Announcement Date
|
3/14/19
|
3/19/20
|
3/18/21
|
3/17/22
|
3/7/23
|
3/6/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
35,975
|
40,990
|
43,790
|
39,023
|
46,253
|
51,383
|
EBITDA
1 |
4,407
|
4,798
|
3,594
|
1,566
|
2,402
|
2,366
|
EBIT
1 |
3,233
|
3,482
|
2,351
|
335.7
|
1,337
|
1,362
|
Operating Margin
|
8.99%
|
8.5%
|
5.37%
|
0.86%
|
2.89%
|
2.65%
|
Earnings before Tax (EBT)
1 |
3,787
|
4,272
|
1,897
|
2,162
|
2,025
|
2,708
|
Net income
1 |
3,561
|
4,093
|
2,188
|
2,356
|
2,155
|
3,069
|
Net margin
|
9.9%
|
9.98%
|
5%
|
6.04%
|
4.66%
|
5.97%
|
EPS
2 |
253.2
|
298.8
|
162.9
|
175.5
|
165.8
|
237.8
|
Free Cash Flow
1 |
806
|
939.5
|
4,613
|
-325.5
|
-4,268
|
6,532
|
FCF margin
|
2.24%
|
2.29%
|
10.53%
|
-0.83%
|
-9.23%
|
12.71%
|
FCF Conversion (EBITDA)
|
18.29%
|
19.58%
|
128.34%
|
-
|
-
|
276.08%
|
FCF Conversion (Net income)
|
22.64%
|
22.95%
|
210.86%
|
-
|
-
|
212.84%
|
Dividend per Share
2 |
70.00
|
70.00
|
70.00
|
-
|
-
|
70.00
|
Announcement Date
|
3/14/19
|
3/19/20
|
3/18/21
|
3/17/22
|
3/7/23
|
3/6/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
133
|
-
|
-
|
-
|
309
|
-
|
Net Cash position
1 |
-
|
935
|
5,002
|
4,653
|
-
|
5,891
|
Leverage (Debt/EBITDA)
|
0.0301
x
|
-
|
-
|
-
|
0.1285
x
|
-
|
Free Cash Flow
1 |
806
|
939
|
4,613
|
-325
|
-4,268
|
6,532
|
ROE (net income / shareholders' equity)
|
11.2%
|
12.2%
|
6.24%
|
6.59%
|
5.93%
|
7.99%
|
ROA (Net income/ Total Assets)
|
4.16%
|
4.24%
|
2.59%
|
0.37%
|
1.49%
|
1.46%
|
Assets
1 |
85,496
|
96,630
|
84,324
|
643,734
|
144,499
|
209,724
|
Book Value Per Share
2 |
2,346
|
2,576
|
2,653
|
2,702
|
2,863
|
3,087
|
Cash Flow per Share
2 |
355.0
|
691.0
|
1,187
|
862.0
|
390.0
|
874.0
|
Capex
1 |
849
|
813
|
691
|
317
|
546
|
515
|
Capex / Sales
|
2.36%
|
1.98%
|
1.58%
|
0.81%
|
1.18%
|
1%
|
Announcement Date
|
3/14/19
|
3/19/20
|
3/18/21
|
3/17/22
|
3/7/23
|
3/6/24
|
|
1st Jan change
|
Capi.
|
---|
| -21.41% | 23.61M | | -31.99% | 1.41B | | +181.31% | 165M | | +18.47% | 127M | | +14.37% | 81.27M |
Biometric Products
|